:: Volume 20, Issue 1 (1-2022) ::
Int J Radiat Res 2022, 20(1): 109-114 Back to browse issues page
Observation of the effectiveness and safety of the combination of chemotherapy and radiotherapy after the radical resection of progressive gastric cancer
X. Yu, R. Zhang, S. Cao, S. Cui, C. Liu, J. Wang, X. Cheng
Department of Radiotherapy Room, Linyi Central Hospital, Linyi, Shandong276400, China , ZHANG.prof@yahoo.com
Abstract:   (773 Views)
Background: To analyze the effectiveness and safety of combination of 3-dimensional conformal radiotherapy (3D-CRT) and S-LOX chemotherapy after the radical resection of localized progressive gastric cancer, so as to provide the reference for clinical treatment. Materials and Methods: We enrolled 82 localized progressive gastric cancer patients undergoing the radical resection of gastric cancer, and divided them using the random digit table into two groups: 39 in the chemotherapy group received the S-LOX chemotherapy after operation, and 43 in the combination group received the 3D-CRT in combination with S-LOX chemotherapy. After treatment, we evaluated the clinical efficacy, adverse reaction, survival rate and recurrence rate of patients in two groups. Results: After 6 cycles of treatment, we found no statistical significance in difference of the objective remission rate of patients in two groups (P > 0.05), while the patients in the combination group excelled in the clinical control rate (P < 0.05). In the combination group, 2-year survival rate and survival time of patients were all higher and longer than those in the chemotherapy group (all P < 0.05), with a lower recurrence rate (P < 0.05). Furthermore, comparison of the incidence of adverse reactions of patients between two groups showed no significant difference (P > 0.05). Conclusion: After the radical resection of the localized progressive gastric cancer,           3D-CRT in combination with S-LOX chemotherapy improves the clinical control and survival of patients, while reduces the postoperative recurrence, but with no aggravation in side- or toxic-effect, thus worthy of being promoted in clinical practice.
Keywords: Progressive gastric cancer, radical resection, chemotherapy, 3D-CRT, prognosis.
Full-Text [PDF 1482 kb]   (507 Downloads)    
Type of Study: Original Research | Subject: Radiobiology

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 1 (1-2022) Back to browse issues page